The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic Experience-Reference-Cited by-同舟云学术

The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic Experience

Published:2021-09 Issue:9 Volume:27 Page:770.e1-770.e7
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Vaxman Iuliana,Muchtar Eli,Jacob Eapen,Kapoor Prashant,Kumar Shaji,Dispenzieri Angela,Buadi Francis,Dingli David,Gonsalves Wilson,Kourelis Taxiarchis,Warsame Rahma,Lacy Martha,Hogan William,Gertz Morie A.

Funder

NIH

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference33 articles.

1. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology;Kumar;J Natl Compr Cancer Netw,2020

2. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management;Rajkumar;Am J Hematol,2020

3. Getting blood out of a stone: identification and management of patients with poor hematopoietic cell mobilization;Chen;Blood Rev,2020

4. Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy;Kumar;Bone Marrow Transplant,2014

5. Impact of plerixafor use at different peripheral blood CD34(+) thresholds on autologous stem cell collection in patients with multiple myeloma;Shah;Biol Blood Marrow Transplant,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization;Transplantation and Cellular Therapy;2024-08

2. Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma;Bone Marrow Transplantation;2024-07-31

3. Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma;Acta Haematologica;2024-05-06

4. Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization;Annals of Hematology;2024-01-25

5. On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost;Frontiers in Oncology;2024-01-17